124 related articles for article (PubMed ID: 24990180)
21. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of collagen, lysyl oxidase and MMP-2 in human periodontal ligament cells by low- and high-level mechanical stretching.
Chen YJ; Jeng JH; Chang HH; Huang MY; Tsai FF; Yao CC
J Periodontal Res; 2013 Aug; 48(4):466-74. PubMed ID: 23190051
[TBL] [Abstract][Full Text] [Related]
23. Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease.
Ballester-Servera C; Alonso J; Cañes L; Vázquez-Sufuentes P; Puertas-Umbert L; Fernández-Celis A; Taurón M; Rodríguez-Sinovas A; López-Andrés N; Rodríguez C; Martínez-González J
Biomed Pharmacother; 2023 Nov; 167():115469. PubMed ID: 37729730
[TBL] [Abstract][Full Text] [Related]
24. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
[TBL] [Abstract][Full Text] [Related]
25. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
[TBL] [Abstract][Full Text] [Related]
26. Lysyl oxidase expression in smooth muscle cells determines the level of intima calcification in hypercholesterolemia-induced atherosclerosis.
Ballester-Servera C; Alonso J; Taurón M; Rotllán N; Rodríguez C; Martínez-González J
Clin Investig Arterioscler; 2024 Feb; ():. PubMed ID: 38402026
[TBL] [Abstract][Full Text] [Related]
27. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
28. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.
Pan S; Kleppe LS; Witt TA; Mueske CS; Simari RD
Thromb Haemost; 2004 Sep; 92(3):495-502. PubMed ID: 15351845
[TBL] [Abstract][Full Text] [Related]
29. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth.
Pez F; Dayan F; Durivault J; Kaniewski B; Aimond G; Le Provost GS; Deux B; Clézardin P; Sommer P; Pouysségur J; Reynaud C
Cancer Res; 2011 Mar; 71(5):1647-57. PubMed ID: 21239473
[TBL] [Abstract][Full Text] [Related]
30. Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels.
Bonta PI; Matlung HL; Vos M; Peters SL; Pannekoek H; Bakker EN; de Vries CJ
Cardiovasc Res; 2010 Aug; 87(3):561-8. PubMed ID: 20189954
[TBL] [Abstract][Full Text] [Related]
31. Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation.
Hurtado PA; Vora S; Sume SS; Yang D; St Hilaire C; Guo Y; Palamakumbura AH; Schreiber BM; Ravid K; Trackman PC
Biochem Biophys Res Commun; 2008 Feb; 366(1):156-61. PubMed ID: 18060869
[TBL] [Abstract][Full Text] [Related]
32. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues.
Mäki JM; Sormunen R; Lippo S; Kaarteenaho-Wiik R; Soininen R; Myllyharju J
Am J Pathol; 2005 Oct; 167(4):927-36. PubMed ID: 16192629
[TBL] [Abstract][Full Text] [Related]
33. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773
[TBL] [Abstract][Full Text] [Related]
34. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
[TBL] [Abstract][Full Text] [Related]
35. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.
Bouez C; Reynaud C; Noblesse E; Thépot A; Gleyzal C; Kanitakis J; Perrier E; Damour O; Sommer P
Clin Cancer Res; 2006 Mar; 12(5):1463-9. PubMed ID: 16533769
[TBL] [Abstract][Full Text] [Related]
36. Lysyl oxidase regulates MMTV promoter: indirect evidence of histone H1 involvement.
Oleggini R; Di Donato A
Biochem Cell Biol; 2011 Dec; 89(6):522-32. PubMed ID: 21999391
[TBL] [Abstract][Full Text] [Related]
37. Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.
Izumi Y; Kim S; Yoshiyama M; Izumiya Y; Yoshida K; Matsuzawa A; Koyama H; Nishizawa Y; Ichijo H; Yoshikawa J; Iwao H
Circulation; 2003 Dec; 108(22):2812-8. PubMed ID: 14638553
[TBL] [Abstract][Full Text] [Related]
38. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
[TBL] [Abstract][Full Text] [Related]
39. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.
van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ
Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726
[TBL] [Abstract][Full Text] [Related]
40. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
